- Home
- RIOT vs MRUS Comparison
RIOT vs MRUS Comparison
Compare RIOT & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIOT
- MRUS
- Stock Information
- Founded
- RIOT 2000
- MRUS 2003
- Country
- RIOT United States
- MRUS Netherlands
- Employees
- RIOT 783
- MRUS N/A
- Industry
- RIOT Retail: Computer Software & Peripheral Equipment
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- RIOT Technology
- MRUS Health Care
- Exchange
- RIOT Nasdaq
- MRUS Nasdaq
- Market Cap
- RIOT 4.5B
- MRUS 4.1B
- IPO Year
- RIOT N/A
- MRUS 2016
- Fundamental
- Price
- RIOT $11.33
- MRUS $67.25
- Analyst Decision
- RIOT Buy
- MRUS Strong Buy
- Analyst Count
- RIOT 10
- MRUS 12
- Target Price
- RIOT $17.03
- MRUS $91.00
- AVG Volume (30 Days)
- RIOT 39.0M
- MRUS 630.0K
- Earning Date
- RIOT 07-31-2025
- MRUS 08-05-2025
- Dividend Yield
- RIOT N/A
- MRUS N/A
- EPS Growth
- RIOT N/A
- MRUS N/A
- EPS
- RIOT N/A
- MRUS N/A
- Revenue
- RIOT $541,719,000.00
- MRUS $56,228,000.00
- Revenue This Year
- RIOT $78.08
- MRUS $67.27
- Revenue Next Year
- RIOT $12.72
- MRUS $0.49
- P/E Ratio
- RIOT N/A
- MRUS N/A
- Revenue Growth
- RIOT 93.46
- MRUS 59.77
- 52 Week Low
- RIOT $6.19
- MRUS $33.19
- 52 Week High
- RIOT $15.87
- MRUS $67.59
- Technical
- Relative Strength Index (RSI)
- RIOT 44.09
- MRUS 64.48
- Support Level
- RIOT $11.22
- MRUS $63.21
- Resistance Level
- RIOT $12.28
- MRUS $67.59
- Average True Range (ATR)
- RIOT 0.78
- MRUS 2.24
- MACD
- RIOT -0.19
- MRUS -0.28
- Stochastic Oscillator
- RIOT 18.45
- MRUS 93.75
About RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.